Evidence map›Paper›PMID 27200104›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2016

The Genus Phyllanthus: An Ethnopharmacological, Phytochemical, and Pharmacological Review.

Xin Mao, Ling-Fang Wu, Hong-Ling Guo, Wen-Jing Chen, Ya-Ping Cui, Qi Qi, Shi Li, Wen-Yi Liang, Guang-Hui Yang, Yan-Yan Shao and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
11.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Article
  3. Therapeutic potential ofRSC advances · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. The complete chloroplast genome sequence ofMitochondrial DNA. Part B, Resources · 2025
    Article
  8. Review
  9. A review ofFrontiers in pharmacology · 2024
    Review
  10. Article
  11. Review
  12. Genome ofFrontiers in plant science · 2023
    Article
  13. Metabolites · 2022
    Article
  14. Article
  15. Article
  16. FreshAntioxidants (Basel, Switzerland) · 2022
    Article
  17. An insight into the potent medicinal plantThe Nucleus : an international journal of cytology and allied topics · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Xin MaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Ling-Fang WuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Hong-Ling GuoInstitute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Wen-Jing ChenSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Ya-Ping CuiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Qi QiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Shi LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Wen-Yi LiangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Guang-Hui YangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Yan-Yan ShaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Dan ZhuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Gai-Mei SheSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Yun YouInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China; Key laboratory of Chinese Internal Medicine, Beijing University of Chinese Medicine, Beijing 100700, China.
Lan-Zhen ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.
Beijing University of Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The plants of the genus Phyllanthus (Euphorbiaceae) have been used as traditional medicinal materials for a long time in China, India, Brazil, and the Southeast Asian countries. They can be used for the treatment of digestive disease, jaundice, and renal calculus. This review discusses the ethnopharmacological, phytochemical, and pharmacological studies of Phyllanthus over the past few decades. More than 510 compounds have been isolated, the majority of which are lignins, triterpenoids, flavonoids, and tannins. The researches of their remarkable antiviral, antioxidant, antidiabetic, and anticancer activities have become hot topics. More pharmacological screenings and phytochemical investigations are required to support the traditional uses and develop leading compounds.

Identifiers

PMID27200104
PMCPMC4854999
OpenAlexW2341488516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.